TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.
| Website: | www.traconpharma.com |
| Main Phone: | +1 858 550-0780 |
| Address: | 4350 La Jolla Village Drive |
| Address 2: | Suite 800 |
| State: | CA |
| City / Town: | San Diego |
| Country: | USA |
| Postal Code: | 92122 |
| Exchange: | NSD |
| CEO: | Charles P. Theuer |
| Employees: | 25 |
| NAICS: | Medicinal and Botanical Manufacturing(325411) |
| Last Price 1.51 | Change $ -0.08 | Change % -5.03 | Tick N/A |
| Bid 1.44 | Bid Size 200.00 | Ask 2.10 | Ask Size 1,000.00 |
| Open 1.60 | High 1.68 | Low 1.49 | Prev Close 1.59 |
| Last Trade | Volume 224,695 | 52 Wk Hi 3.60 | 52 Wk Low 1.49 |
| Market Cap 45.1 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 29,840,844.00 | EPS (TTM) -1.10 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 18 | 21 |
| Number of Buys | 18 | 18 |
| Number of Sells | 0 | 3 |
| Net Activity | 12743352 | 12727428 |
| Last 10 Buys | Shares |
|---|---|
| Peter Sonsini | 1,000 |
| Peter Sonsini | 1,000 |
| Ravi Viswanathan | 1,000 |
| Ravi Viswanathan | 1,000 |
| David M. Mott | 1,000 |
| David M. Mott | 1,000 |
| Sandell D Scott | 1,000 |
| Sandell D Scott | 1,000 |
| Anthony A. Florence | 1,000 |
| Anthony A. Florence | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| William R. Larue | 1,000 |
| Ronald L. Shazer | 1,000 |
| Charles P. Theuer | 1,000 |
| H Casey Logan | 1,000 |
| Charles P. Theuer | 1,000 |
| Charles P. Theuer | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 6 | 6 | 6 | 6 |
| Low Target Price Estimate | 5.5 | 5.5 | 5.5 | 5.5 |
| Mean Target Price Estimate | 5.75 | 5.75 | 5.75 | 5.75 |
| Standard Deviation | 0.35 | 0.35 | 0.35 | 0.35 |
| Date of Most Recent Estimate | 05/15/18 | 05/15/18 | 05/15/18 | 05/15/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-05-30 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2 | 2 | 1.67 | 1.67 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
